1[1]Beck S, Aguado B, Bahram S, et al. The MHC sequencing consortium:complete sequence and gene map of a human major histocompatibility complex[J].Nature,1999,401(8):921.
2[2]Henslee-Downey PF, Abhyankar SH, Parrish RS, et al. Use of partially mismatehed related donors extends access to allogeneic marrow transplant[J].Blood,1997,89(10):3864.
3[3]Goldman FD, Rumelhart SL, DeAlacron P, et al. Poor outcome in children with refractory or relapsed leukemia undergoing bone marrow transplantation with mismatched family menber donors[J].Bone Marrow Transplant,2000,25(5):943.
4[4]Henslee-Downey PJ, Parrish RS, Mac Donald JS, et al. Combined in vitro and in vivo T lymphocyte depletion for the control of graft versus host disease following haploidentical marrow transplant[J].Transplantation,1996,61(4):738.
5[5]Kawano Y, Takaue Y, Watanabe A,et al.Partially mismatched pediatric transplant with allogeneic CD34+ blood cells from a related donor[J].Blood,1998,92(6):3123.
6[6]Bahceci E, Read EJ, Leitman S, et al. CD34+ cell dose predicts relapse and survival after T cell depleted HLA identical haematopoietic stem cell transplantation for haematological malignancies[J].Br J Haematol,2000,108(3):408.
7[7]Beelen DW, Ottinger HD, Elmaagacli A, et al. Transplantation of filgrastim mobilized peripheral blood stem cells from HLA-indentical sibling or alternative family donors in patients with hematologic malignancies:a prospective comparison on clinical outcome, immune reconstitution,and hematopoietic chimerism[J].Blood,1997,90(8):4725.
8[8]Bacigalupo A, Mordini N, Pitto A, et al. Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies:severe immunodeficiency and related complications[J].Br J Haematol,1997,98(4):760.
9[9]Schumn M, Lang P, Taylor G, et al. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the clini MACS device[J].J Hematother,1999,8(2):209.
10[10]Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype[J].N Engl J Med,1998,339(6):1186.
同被引文献9
1Wang H, Tokunaga K, Lshikawa Y, et al. A high-resolution genotyping mwthod for HLA-C alleles and possible shared HLA-C-B haplotypes hetween Japanese and Caucasians. Tissue Antigens 1997; 50(6): 620 -6
2Piancatelli D, Canossi A, Ayreli A, et al. Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing. Tissue Antigens 2004; 63 (2): 158 -72
3van der Meer A, Allebes WA, Paardekooper J, et al. HLA-C mismatches induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-mediated alloreactivity. Transplantation 2001; 72(5): 923 - 9
4Karabon L, Polak M, Pacuszko T, et al. HLA typing for donor-recipient matching in unrelated donor hematopotetic stem cell transplantation. Transplant Proc 2002;34(2): 668 -70
5Tanaka J, Tutumi Y, Mori A, et al. Sequential analysis of HLA-C-specific killer cell inhibitory receptor(CD1586) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease. Bone Marrow Transplant 2000; 26(3):287 - 90
